SCHEMBL7653405

SCHEMBL7653405

CC(C)(C)[Si](C)(C)Oc1ccc([C@H]2CC[C@H](N(Cc3ccccc3)OC(=O)c3ccccc3)CC2)c(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 2/20 0.35
SMYD3 Q9H7B4 3/20 0.33
TRPM8 Q7Z2W7 2/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
CCNC P24863 1/20 0.31
CDK8 P49336 1/20 0.31
ACHE P22303 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
UBE2M P61081 1/20 0.31
DCUN1D1 Q96GG9 1/20 0.31
SLC7A5 Q01650 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
RBP4 P02753 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7064802 1.00 MRGPRX4 (0.35) MRGPRX4SMYD3TRPM8HSP90AA1HSP90AB1
SCHEMBL7062211 1.00 MRGPRX4 (0.35) MRGPRX4SMYD3TRPM8HSP90AA1HSP90AB1
SCHEMBL7063409 0.80 HSP90AA1 (0.35) MRGPRX4HSP90AA1HSP90AB1MEN1KMT2A
SCHEMBL7063406 0.80 HSP90AA1 (0.35) MRGPRX4HSP90AA1HSP90AB1MEN1KMT2A
SCHEMBL6806719 0.79 HSP90AA1 (0.35) TRPM8HSP90AA1HSP90AB1S1PR1S1PR3
SCHEMBL6806711 0.79 HSP90AA1 (0.35) TRPM8HSP90AA1HSP90AB1S1PR1S1PR3
SCHEMBL7058680 0.78 KDM4E (0.35) HSP90AA1HSP90AB1CCNCCDK8MEN1
SCHEMBL7058684 0.78 KDM4E (0.35) HSP90AA1HSP90AB1CCNCCDK8MEN1
SCHEMBL7255762 0.78 KDM4E (0.35) HSP90AA1HSP90AB1CCNCCDK8MEN1
SCHEMBL7062208 0.77 ELANE (0.35) MRGPRX4HSP90AA1HSP90AB1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020137961-A1 Resorcinol derivatives PFIZER INC. 2002-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137961-A1 Resorcinol derivatives LRAT, NQO1, ALDH1A2 MRGPRX4 790/4885SMYD3 2788/4885TRPM8 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.